Why Aegerion Pharmaceuticals (AEGR) Stock Is Down Today

NEW YORK (TheStreet) -- Aegerion Pharmaceuticals  (AEGR) fell Tuesday after the company announced the pricing of its offering of $300 million aggregate principal amount of 2% convertible senior notes due 2019.

The offering includes an option for initial purchasers to buy up to an additional $45 million aggregate principal amount of notes to cover overallotments. The conversion rate for the notes will start at 24.2866 shares of Aegerion common stock per $1,000 principal amount of notes, or approximately $41.175 per share. This represents a 35% premium to the stock's closing price of $30.50 on Monday.

The stock was down 1.44% to $30.06 at 10:47 a.m. More than 2.1 million shares had changed hands, compared to the average volume of 984,766.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

AEGR Chart AEGR data by YCharts

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Stocks Rise Sharply, Facebook Ignites a Nasdaq Rally

Stocks Rise Sharply, Facebook Ignites a Nasdaq Rally

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company

Jim Cramer: Visa Is a Technology Company That Masquerades as a Financial Company

Jim Cramer: Chipotle Shares Are Probably Done Going Down

Jim Cramer: Chipotle Shares Are Probably Done Going Down

Jim Cramer: This Is a Sad Time for Southwest Airlines

Jim Cramer: This Is a Sad Time for Southwest Airlines

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations